Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$1.11M

Rothblatt Martine A Chairperson & CEO

Transaction date Aug 19, 2026
Public filing date Aug 20, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$529.14 Aug 19, 2026
First close after public filing
$513.12 Aug 21, 2026
30-day return after filing
-3.9% Through Sep 21, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
2,105 shares @ $526.76
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000124
Filing cohort

Transactions in this filing

Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$6.29M
Buys / sales
0 / 12
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Sale Aug 19, 2026 $470.41K
United Therapeutics Corp UTHR Exercise Aug 19, 2026 $1.29M
United Therapeutics Corp UTHR Sale Aug 19, 2026 $125.4K
United Therapeutics Corp UTHR Current Sale Aug 19, 2026 $1.11M
United Therapeutics Corp UTHR Sale Aug 19, 2026 $1.13M
United Therapeutics Corp UTHR Sale Aug 19, 2026 $231.31K
United Therapeutics Corp UTHR Sale Aug 19, 2026 $42.82K
United Therapeutics Corp UTHR Sale Aug 19, 2026 $661.89K
United Therapeutics Corp UTHR Sale Aug 19, 2026 $634.3K
United Therapeutics Corp UTHR Sale Aug 19, 2026 $348.98K
United Therapeutics Corp UTHR Sale Aug 19, 2026 $106.73K
United Therapeutics Corp UTHR Sale Aug 19, 2026 $42.53K
United Therapeutics Corp UTHR Sale Aug 19, 2026 $106.53K
United Therapeutics Corp UTHR Exercise Aug 19, 2026 $0